Two new drugs use antibodies to deliver radiation directly to the tumor cell.
Combines antibody with yttrium-90 for treatment of non-Hodgkin's lymphoma
Maker: IDEC Pharmaceuticals
Status: Recommended by FDA advisory panel on Sept. 11
Antibody combined with iodine-131, also for non-Hodgkin's
Status: Completed FDA application filing on Sept. 7